CIARA ANTOLIN: Open Payments
NPI 1740047703 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $350 · 2025 $1,340
Food & beverage: $1,324Education: $16
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $339 |
| Amgen Inc. | 2 | $171 |
| Novo Nordisk Inc | 2 | $130 |
| Lundbeck LLC | 1 | $121 |
| BETA BIONICS, INC. | 2 | $119 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| ABBVIE INC. | 1 | $88 |
| Insulet Corporation | 1 | $24 |
Products named: Dexcom G6 Transmitter, OTEZLA, Ozempic, VYEPTI, iLet Bionic Pancreas, VOQUEZNA, CAPLYTA, CAPVAXIVE.
Industry payments across VA — which companies pay providers there.
